(Expressed in thousands of Euros)
|
|
Bioscience |
|
Hospital |
|
Diagnostic |
|
Bio Supplies |
|
Others |
|
Intersegments |
|
Consolidated |
|
|||||||||||||||||||||||||||||
|
|
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
2017 |
|
2016 |
|
2015 |
|
|
Revenues from external customers |
|
3,429,785 |
|
3,195,424 |
|
3,032,111 |
|
105,649 |
|
102,251 |
|
96,245 |
|
732,369 |
|
691,701 |
|
716,838 |
|
66,791 |
|
57,239 |
|
24,466 |
|
18,263 |
|
34,601 |
|
90,289 |
|
(34,784 |
) |
(31,386 |
) |
(25,386 |
) |
4,318,073 |
|
4,049,830 |
|
3,934,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating income |
|
3,429,785 |
|
3,195,424 |
|
3,032,111 |
|
105,649 |
|
102,251 |
|
96,245 |
|
732,369 |
|
691,701 |
|
716,838 |
|
66,791 |
|
57,239 |
|
24,466 |
|
18,263 |
|
34,601 |
|
90,289 |
|
(34,784 |
) |
(31,386 |
) |
(25,386 |
) |
4,318,073 |
|
4,049,830 |
|
3,934,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit/(Loss) for the segment |
|
985,495 |
|
913,840 |
|
896,032 |
|
(9,766 |
) |
(8,765 |
) |
(4,299 |
) |
248,080 |
|
97,320 |
|
96,268 |
|
35,598 |
|
33,794 |
|
3,660 |
|
(9,632 |
) |
44,324 |
|
77,982 |
|
(12,305 |
) |
(1,316 |
) |
(305 |
) |
1,237,470 |
|
1,079,197 |
|
1,069,338 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(234,127 |
) |
(139,789 |
) |
(98,968 |
) |
|
Operating profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,003,343 |
|
939,408 |
|
970,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance result |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(287,734 |
) |
(233,589 |
) |
(271,840 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of profit/(loss) of equity accounted investee |
|
(10,434 |
) |
(9,396 |
) |
— |
|
2,112 |
|
(5,611 |
) |
— |
|
(9,335 |
) |
— |
|
— |
|
1,830 |
|
— |
|
— |
|
(4,060 |
) |
21,940 |
|
(8,280 |
) |
— |
|
— |
|
— |
|
(19,887 |
) |
6,933 |
|
(8,280 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(34,408 |
) |
(168,209 |
) |
(158,809 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year after tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
661,314 |
|
544,543 |
|
531,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment assets |
|
6,007,153 |
|
6,524,922 |
|
6,085,211 |
|
145,477 |
|
86,590 |
|
91,877 |
|
3,356,185 |
|
1,909,447 |
|
1,794,389 |
|
7,409 |
|
8,378 |
|
1,321 |
|
60,449 |
|
40,160 |
|
106,374 |
|
(22,196 |
) |
(11,964 |
) |
(10,240 |
) |
9,554,477 |
|
8,557,533 |
|
8,068,932 |
|
|
Equity accounted investments |
|
83,905 |
|
104,996 |
|
— |
|
— |
|
13,888 |
|
— |
|
29,322 |
|
43,330 |
|
— |
|
44,220 |
|
— |
|
— |
|
61,562 |
|
39,131 |
|
76,728 |
|
— |
|
— |
|
— |
|
219,009 |
|
201,345 |
|
76,728 |
|
|
Unallocated assets |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
1,146,778 |
|
1,370,894 |
|
1,456,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,920,264 |
|
10,129,772 |
|
9,601,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment liabilities |
|
423,415 |
|
411,604 |
|
387,086 |
|
13,560 |
|
8,415 |
|
3,159 |
|
192,720 |
|
186,389 |
|
192,730 |
|
— |
|
— |
|
— |
|
26,903 |
|
1,843 |
|
209,405 |
|
— |
|
— |
|
— |
|
656,598 |
|
608,251 |
|
792,380 |
|
|
Unallocated liabilities |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
6,629,701 |
|
5,793,543 |
|
5,507,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,286,299 |
|
6,401,794 |
|
6,300,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortisation and depreciation allocated |
|
157,478 |
|
152,821 |
|
137,870 |
|
6,436 |
|
5,915 |
|
5,710 |
|
40,815 |
|
32,180 |
|
31,875 |
|
— |
|
— |
|
— |
|
2,237 |
|
3,445 |
|
6,946 |
|
— |
|
— |
|
— |
|
206,966 |
|
194,361 |
|
182,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortisation and depreciation unallocated |
|
|
|
— |
|
— |
|
|
|
— |
|
— |
|
|
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
8,524 |
|
7,508 |
|
7,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses that do not requirecash payments allocated |
|
7,049 |
|
16,219 |
|
627 |
|
(514 |
) |
306 |
|
108 |
|
(4,423 |
) |
(2,001 |
) |
4,630 |
|
— |
|
— |
|
— |
|
— |
|
(32,534 |
) |
— |
|
— |
|
— |
|
— |
|
2,112 |
|
(18,010 |
) |
5,365 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses that do not require cash payments unallocated |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(58,752 |
) |
4,608 |
|
4,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions for the year of property, plant & equipment and intangible assets allocated |
|
227,635 |
|
197,741 |
|
421,020 |
|
10,429 |
|
9,193 |
|
7,972 |
|
70,032 |
|
89,760 |
|
68,740 |
|
198 |
|
84 |
|
— |
|
20,911 |
|
13,313 |
|
— |
|
— |
|
— |
|
— |
|
329,205 |
|
310,091 |
|
497,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions for the year of property, plant & equipment and intangible assets unallocated |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
11,268 |
|
12,011 |
|
79,082 |
|
* As a result of the creation of Bio Supplies segment and intersegments, the Group has reviewed the allocation of balances and transactions by segments. The comparative figures for years 2016 and 2015 have been restated accordingly.
This appendix forms an integral part of note 6 to the consolidated financial statements